• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖-叶酸修饰的聚乳酸-羟基乙酸共聚物纳米粒用于靶向递送薯蓣皂苷元作为抗癌剂的研究进展

Development of chitosan-folate modified PLGA nanoparticles for targeted delivery of diosgenin as an anticancer agent.

作者信息

Teymouri Fatemeh, Karimi Ehsan

机构信息

Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

出版信息

Discov Oncol. 2024 Apr 3;15(1):100. doi: 10.1007/s12672-024-00957-7.

DOI:10.1007/s12672-024-00957-7
PMID:38568336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10992453/
Abstract

Diosgenin as a potential phytoconstituent and steroidal saponin manifested significant anticancer agents against various cancers. To enhance its solubility and bioavailability in cancer treatment, we loaded diosgenin (PubChem CID: 99474) in poly(lactic-co-glycolide) (PLGA) nanoparticle coated with folic acid-chitosan (Da-PFC-NPs). The diosgenin nano-formulation was characterized and its antioxidant and anticancer properties were surveyed respectively. The obtained results illustrated that the Da-PFC-NPs were spherical and stable with a size of 218 nm and a polydispersity index of 0.41. The Da-PFC-NPs indicated potential free radical scavenging using ABTS and DPPH assay. Meanwhile, it demonstrated selective toxicity against the TUBO breast cancer cell with IC values of 104.45 μg/ml and did not show toxicity on normal cells (I929 cell line). The invivo funding exhibited that Da-PFC-NPs notably  altered the liver enzymes (AST, ALT, ALP) and immunoglobulins (IgA, IgG, IgM). Besides that, different doses of Da-PFC-NPs (50 and 100 mg/kg) remarkedly enhance the expression of caspase 3 and decrease HER2 genes. In light of this experiment, we can conclude that Da-PFC-NPs have promise as novel carrier for improving the delivery of diosgenin in cancer therapy.

摘要

薯蓣皂苷元作为一种潜在的植物成分和甾体皂苷,是针对多种癌症的重要抗癌剂。为提高其在癌症治疗中的溶解度和生物利用度,我们将薯蓣皂苷元(PubChem CID:99474)负载于包覆有叶酸-壳聚糖的聚乳酸-羟基乙酸共聚物(PLGA)纳米颗粒(Da-PFC-NPs)中。对薯蓣皂苷元纳米制剂进行了表征,并分别研究了其抗氧化和抗癌特性。所得结果表明,Da-PFC-NPs呈球形且稳定,粒径为218 nm,多分散指数为0.41。通过ABTS和DPPH测定法,Da-PFC-NPs显示出潜在的自由基清除能力。同时,它对TUBO乳腺癌细胞表现出选择性毒性,IC值为104.45 μg/ml,对正常细胞(I929细胞系)未显示毒性。体内研究表明,Da-PFC-NPs显著改变了肝酶(AST、ALT、ALP)和免疫球蛋白(IgA、IgG、IgM)。此外,不同剂量的Da-PFC-NPs(50和100 mg/kg)显著提高了caspase 3的表达并降低了HER2基因。鉴于该实验,我们可以得出结论,Da-PFC-NPs有望作为新型载体改善薯蓣皂苷元在癌症治疗中的递送。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/494bb073b6ce/12672_2024_957_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/aa5c218102c9/12672_2024_957_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/263970686e0b/12672_2024_957_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/f58fdbf4c8c8/12672_2024_957_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/99a550ba1307/12672_2024_957_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/46e6185131a5/12672_2024_957_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/3c6ac506a9da/12672_2024_957_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/97d2a8c3f33c/12672_2024_957_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/494bb073b6ce/12672_2024_957_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/aa5c218102c9/12672_2024_957_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/263970686e0b/12672_2024_957_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/f58fdbf4c8c8/12672_2024_957_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/99a550ba1307/12672_2024_957_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/46e6185131a5/12672_2024_957_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/3c6ac506a9da/12672_2024_957_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/97d2a8c3f33c/12672_2024_957_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0692/10992453/494bb073b6ce/12672_2024_957_Fig8_HTML.jpg

相似文献

1
Development of chitosan-folate modified PLGA nanoparticles for targeted delivery of diosgenin as an anticancer agent.壳聚糖-叶酸修饰的聚乳酸-羟基乙酸共聚物纳米粒用于靶向递送薯蓣皂苷元作为抗癌剂的研究进展
Discov Oncol. 2024 Apr 3;15(1):100. doi: 10.1007/s12672-024-00957-7.
2
Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.使用 EGF 功能化的 PLGA 纳米载体制备负载 5-氟尿嘧啶和全氟碳的纳米粒,增强结肠癌的抗肿瘤疗效。
BMC Cancer. 2020 Apr 28;20(1):354. doi: 10.1186/s12885-020-06803-7.
3
Nanofabrication of PLGA-PEG-chitosan-folic acid systems for delivery of colchicine to HT-29 cancer cells.聚乳酸-羟基乙酸共聚物-聚乙二醇-壳聚糖-叶酸系统的纳米制备及其用于秋水仙碱向 HT-29 癌细胞的递送。
J Biomater Sci Polym Ed. 2023 Jan;34(1):1-17. doi: 10.1080/09205063.2022.2105103. Epub 2022 Jul 28.
4
Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.新型多西紫杉醇壳聚糖包覆的 PLGA/PCL 纳米粒,具有增强的细胞毒性和生物利用度。
Biomed Pharmacother. 2018 Oct;106:1461-1468. doi: 10.1016/j.biopha.2018.07.102. Epub 2018 Jul 24.
5
Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.叶酸受体靶向的 PLGA-PEG 纳米粒增强大豆黄素在卵巢癌中的活性。
Artif Cells Nanomed Biotechnol. 2022 Dec;50(1):228-239. doi: 10.1080/21691401.2022.2118758.
6
Folate-receptor-targeted laser-activable poly(lactide--glycolic acid) nanoparticles loaded with paclitaxel/indocyanine green for photoacoustic/ultrasound imaging and chemo/photothermal therapy.载紫杉醇/吲哚菁绿的叶酸受体靶向激光激活聚乳酸-乙醇酸纳米粒用于光声/超声成像及化疗/光热治疗。
Int J Nanomedicine. 2018 Sep 6;13:5139-5158. doi: 10.2147/IJN.S167043. eCollection 2018.
7
Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics.口服载多西他赛的壳聚糖修饰阳离子聚乳酸-羟基乙酸共聚物纳米粒用于肠道肿瘤:制剂、全面的体外表征及释放动力学
Beilstein J Nanotechnol. 2022 Nov 23;13:1393-1407. doi: 10.3762/bjnano.13.115. eCollection 2022.
8
Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.载硫喷妥钠 PLGA 纳米粒的制备及体外评价。
Drug Deliv. 2016;23(3):787-93. doi: 10.3109/10717544.2014.916765. Epub 2014 May 28.
9
Bioavailability of Orally Delivered Alpha-Tocopherol by Poly(Lactic-Co-Glycolic) Acid (PLGA) Nanoparticles and Chitosan Covered PLGA Nanoparticles in F344 Rats.聚乳酸-乙醇酸共聚物(PLGA)纳米颗粒和壳聚糖包被的PLGA纳米颗粒口服给药α-生育酚在F344大鼠中的生物利用度
Nanobiomedicine (Rij). 2016 Jan 1;3:8. doi: 10.5772/63305. eCollection 2016 Jan-Dec.
10
Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.高分子纳米颗粒的细胞内靶向激活克服了人原发性乳腺癌细胞的化学药物耐药性。
Int J Nanomedicine. 2018 Nov 29;13:8153-8164. doi: 10.2147/IJN.S182184. eCollection 2018.

引用本文的文献

1
Harnessing Thalassochemicals: Marine Saponins as Bioactive Agents in Nutraceuticals and Food Technologies.利用海洋化学成分:海洋皂苷作为营养保健品和食品技术中的生物活性剂
Mar Drugs. 2025 May 26;23(6):227. doi: 10.3390/md23060227.
2
Nanoscale strides: exploring innovative therapies for breast cancer treatment.纳米尺度的进展:探索乳腺癌治疗的创新疗法。
RSC Adv. 2024 Apr 29;14(20):14017-14040. doi: 10.1039/d4ra02639j. eCollection 2024 Apr 25.

本文引用的文献

1
Evaluation of the effect of designed PLGA-arctiin nanoparticles modified with folic acid and chitosan on colon cancer cells.评价设计的载阿魏酸聚乳酸-羟基乙酸共聚物纳米粒经叶酸和壳聚糖修饰后对结肠癌细胞的作用。
Biotechnol Appl Biochem. 2024 Feb;71(1):72-80. doi: 10.1002/bab.2522. Epub 2023 Oct 10.
2
Nanofabrication of PLGA-PEG-chitosan-folic acid systems for delivery of colchicine to HT-29 cancer cells.聚乳酸-羟基乙酸共聚物-聚乙二醇-壳聚糖-叶酸系统的纳米制备及其用于秋水仙碱向 HT-29 癌细胞的递送。
J Biomater Sci Polym Ed. 2023 Jan;34(1):1-17. doi: 10.1080/09205063.2022.2105103. Epub 2022 Jul 28.
3
Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha terpineol in colon cancer.
叶酸偶联壳聚糖修饰的 PLGA 纳米粒的制备及评价用于结肠癌中α-松油醇的递送。
J Biomater Sci Polym Ed. 2022 Jul;33(10):1289-1307. doi: 10.1080/09205063.2022.2051693. Epub 2022 Mar 14.
4
Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.用于癌症靶向的脂质工程多功能纳米植物药的最新进展。
J Control Release. 2021 Dec 10;340:48-59. doi: 10.1016/j.jconrel.2021.10.025. Epub 2021 Oct 23.
5
Natural products in drug discovery: advances and opportunities.天然产物在药物发现中的应用:进展与机遇。
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z. Epub 2021 Jan 28.
6
Evaluation of antioxidant, anti-inflammatory and anticancer activities of diosgenin enriched Paris polyphylla rhizome extract of Indian Himalayan landraces.评价印度喜马拉雅地区地方品种珠芽蓼根茎提取物中二仙皂苷元的抗氧化、抗炎和抗癌活性。
J Ethnopharmacol. 2021 Apr 24;270:113842. doi: 10.1016/j.jep.2021.113842. Epub 2021 Jan 16.
7
Chlorogenic acid induces 4T1 breast cancer tumor's apoptosis via p53, Bax, Bcl-2, and caspase-3 signaling pathways in BALB/c mice.绿原酸通过 p53、Bax、Bcl-2 和 caspase-3 信号通路诱导 BALB/c 小鼠 4T1 乳腺癌肿瘤细胞凋亡。
J Biochem Mol Toxicol. 2021 Feb;35(2):e22642. doi: 10.1002/jbt.22642. Epub 2020 Oct 15.
8
Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases.薯蓣皂苷元,一种甾体皂苷,及其类似物:针对不同慢性疾病的有效疗法。
Life Sci. 2020 Nov 1;260:118182. doi: 10.1016/j.lfs.2020.118182. Epub 2020 Aug 8.
9
Plumbagin inhibited AKT signaling pathway in HER-2 overexpressed-endocrine resistant breast cancer cells.白花丹素抑制 HER-2 过表达内分泌耐药乳腺癌细胞中的 AKT 信号通路。
Eur J Pharmacol. 2020 Feb 5;868:172878. doi: 10.1016/j.ejphar.2019.172878. Epub 2019 Dec 19.
10
Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay.载薯蓣皂苷元的尼森体作为有效的植物化学纳米载体:理化特性表征、载药效率和细胞毒性测定。
Daru. 2019 Jun;27(1):329-339. doi: 10.1007/s40199-019-00277-0. Epub 2019 May 27.